thrombin

Trials studying thrombin

• —An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatmentrecruitingn=40
• phase3A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or Brecruitingn=85
• N/AThrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosisrecruitingn=212
• phase3A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophiliaactive not recruitingn=91
• phase3Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypassrecruitingn=120
• phase4A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumabrecruitingn=20
• —Treatment of Hemophilia A Patients With FVIII Inhibitorsrecruitingn=120
• phase1A Study to Assess the Reversal of the Anticoagulant Effects of Milvexian by 4-Factor Prothrombin Complex Concentrate (4F-PCC) (Part 1) and Recombinant Human Factor VIIa (rFVIIa) (Part 2) in Healthy Participantscompletedn=52